U.S. Pharmaceutical Packaging Services Market Size, Share & Trends Analysis Report By Product (Branded, Generic, Biosimilar, Vaccine, Cell Therapy, Gene Therapy), By Service Line, By Manufacturer Size, And Segment Forecasts, 2025 - 2030

The U.S. pharmaceutical packaging services market size is anticipated to reach USD 4.65 billion by 2030 and is anticipated to expand at a CAGR of 9.0% from 2025 to 2030. The U.S. pharmaceutical industry is heavily regulated by agencies such as the Food and Drug Administration (FDA), which mandates strict packaging guidelines to ensure product safety, efficacy, and quality. These regulations drive demand for specialized packaging services, including inspections, certifications, and audits, to maintain compliance. In addition, the growing focus on preventing counterfeit drugs has accelerated the adoption of secure and tamper-evident packaging solutions. This has led to increased investment in advanced technologies such as serialization, barcoding, and RFID for tracking and authentication, boosting the pharmaceutical packaging services market.

The growing prevalence of chronic diseases and the rise in biopharmaceuticals have spurred the demand for innovative packaging solutions that cater to complex formulations, such as biologics and injectable. This has driven the need for customized primary packaging services, including vials, ampoules, and pre-filled syringes, which ensure product stability and dosage precision. Furthermore, the shift toward patient-centric healthcare has amplified the need for user-friendly packaging designs, such as easy-open blister packs and dose-tracking mechanisms. These advancements underscore the role of packaging design services, including 3D prototypes and structural analysis, in meeting evolving consumer and industry needs.

The expansion of e-commerce for prescription and over-the-counter drugs has increased the demand for robust secondary and tertiary packaging solutions that ensure product safety during transit. In addition, the rise in temperature-sensitive pharmaceutical products, such as vaccines and biologics, has fueled the need for cold chain packaging services. This includes insulated containers and temperature-monitoring technologies, which are crucial for maintaining product integrity. As a result, the pharmaceutical packaging services market in the U.S. is experiencing significant growth, driven by the need for reliable and efficient logistics solutions.

U.S. Pharmaceutical Packaging Services Market Highlights

• The branded Product segment accounted for the largest share of over 27.0% of the market in 2024. The biosimilar Product segment is expected to grow at the fastest CAGR of 9.8% during the forecast period.
• Based on service line, the primary packaging segment dominated the U.S. pharmaceutical packaging services market in 2024, accounting for the largest revenue share of over 43.0%.
• Based on manufacturer size, the small manufacturer size segment dominated the U.S. pharmaceutical packaging services market in 2024 by accounting for the largest revenue share of over 58.0%.
• In October 2023, Sharp Services, LLC announced the acquisition of Berkshire Sterile Manufacturing (BSM), a Massachusetts-based contract development and manufacturing organization specializing in sterile injectable products. This acquisition aimed to enhance Sharp Services' capabilities in the biopharmaceutical sector by providing a fully integrated service for small-to-medium-scale sterile injectables, which includes manufacturing, clinical trial services, commercial packaging, and distribution.

This product will be delivered within 2 business days.